Date | Name | Symbol | Type | Security | Shares | Price | Value | Ownership | Reported |
06/14/2023 | Arcellx, Inc. | | Grant | Stock Option (right to buy) | 11.5k | $37.94 | $434.8k | | 06/14/2023 |
06/01/2023 | POINT Biopharma Global Inc. | PNT | Grant | Stock Option (Right to Buy) | 44.7k | $9.12 | $408.1k | | 06/01/2023 |
05/26/2023 | Vor Biopharma Inc. | | Grant | Stock Option (right to buy) | 30k | $4.79 | $143.7k | | 05/26/2023 |
05/24/2023 | Dyne Therapeutics, Inc. | | Grant | Stock Option (right to buy) | 24.9k | $13.49 | $335.9k | | 05/24/2023 |
11/23/2022 | POINT Biopharma Global Inc. | PNT | Purchase | Common Stock | 3.6k | $6.85 | $24.7k | | 11/23/2022 |
07/05/2022 | Dyne Therapeutics, Inc. | | Grant | Stock Option (right to buy) | 7.2k | $5.54 | $40k | | 07/05/2022 |
06/14/2022 | Vor Biopharma Inc. | | Grant | Stock Option (right to buy) | 16.9k | $4.26 | $72k | | 06/14/2022 |
06/03/2022 | Dyne Therapeutics, Inc. | | Grant | Stock Option (right to buy) | 19.6k | $4.58 | $89.7k | | 06/03/2022 |
06/02/2022 | POINT Biopharma Global Inc. | PNT | Grant | Stock Option (Right to Buy) | 25.6k | $8.31 | $212.9k | | 06/02/2022 |
02/08/2022 | Arcellx, Inc. | | Conversion | Common Stock | 21.7k | $0.00 | $0 | | 02/08/2022 |
02/08/2022 | Arcellx, Inc. | | Conversion | Series C Preferred Stock | 21.7k | $0.00 | $0 | | 02/08/2022 |
02/03/2022 | Arcellx, Inc. | | Grant | Stock Option (right to buy) | 61.5k | $15.00 | $923.1k | | 02/03/2022 |
10/04/2021 | Disc Medicine, Inc. | | Grant | Stock Option (Right to Buy) | 0 | $0.00 | $0 | | 10/04/2021 |
10/04/2021 | Disc Medicine, Inc. | | Grant | Stock Option (Right to Buy) | 17.2k | $3.80 | $65.5k | | 10/04/2021 |
07/06/2021 | POINT Biopharma Global Inc. | PNT | Grant | Stock Option (Right to Buy) | 25k | $8.47 | $211.8k | | 07/06/2021 |
05/26/2021 | Dyne Therapeutics, Inc. | | Grant | Stock Option (right to buy) | 19.6k | $19.56 | $383.3k | | 05/26/2021 |
03/12/2021 | Disc Medicine, Inc. | | Grant | Stock Option (Right to Buy) | 17.5k | $17.00 | $298k | | 03/12/2021 |
03/12/2021 | Disc Medicine, Inc. | | Grant | Stock Option (Right to Buy) | 25k | $17.00 | $425k | | 03/12/2021 |
02/05/2021 | Disc Medicine, Inc. | | Grant | Stock Option (Right to Buy) | 58.9k | $12.66 | $745.1k | | 03/12/2021 |
02/05/2021 | Vor Biopharma Inc. | | Grant | Stock Option (right to buy) | 16.9k | $18.00 | $304.2k | | 02/05/2021 |
09/21/2020 | Dyne Therapeutics, Inc. | | Conversion | Series B Preferred Stock | 177.9k | $0.00 | $0 | | 07/31/2020 |
09/21/2020 | Dyne Therapeutics, Inc. | | Conversion | Common Stock | 53.6k | $0.00 | $0 | | 07/31/2020 |
08/07/2020 | Dyne Therapeutics, Inc. | | Purchase | Series B Preferred Stock | 177.9k | $2.81 | $500k | | 07/31/2020 |
07/31/2020 | Dyne Therapeutics, Inc. | | Grant | Stock Option (right to buy) | 11.2k | $5.54 | $61.8k | | 07/31/2020 |
07/31/2020 | Dyne Therapeutics, Inc. | | Grant | Stock Option (right to buy) | 14.4k | $5.54 | $80k | | 07/31/2020 |
04/02/2020 | Ra Pharmaceuticals, Inc. | RARX | Disposition | Common Stock | 15.6k | $48.00 | $749.9k | | 04/02/2020 |
04/02/2020 | Ra Pharmaceuticals, Inc. | RARX | Disposition | Stock Option (Right to Buy) | 115.6k | $2.87 | $331.7k | | 04/02/2020 |
04/02/2020 | Ra Pharmaceuticals, Inc. | RARX | Disposition | Stock Option (Right to Buy) | 92.3k | $2.87 | $264.9k | | 04/02/2020 |
04/02/2020 | Ra Pharmaceuticals, Inc. | RARX | Disposition | Stock Option (Right to Buy) | 28.6k | $5.60 | $160k | | 04/02/2020 |
04/02/2020 | Ra Pharmaceuticals, Inc. | RARX | Disposition | Stock Option (Right to Buy) | 112.5k | $16.64 | $1.9M | | 04/02/2020 |
04/02/2020 | Ra Pharmaceuticals, Inc. | RARX | Disposition | Stock Option (Right to Buy) | 62.5k | $7.33 | $458.1k | | 04/02/2020 |
04/02/2020 | Ra Pharmaceuticals, Inc. | RARX | Disposition | Stock Option (Right to Buy) | 133k | $21.00 | $2.8M | | 04/02/2020 |
04/02/2020 | Ra Pharmaceuticals, Inc. | RARX | Disposition | Restricted Stock Units | 10.4k | $0.00 | $0 | | 04/02/2020 |
06/07/2019 | Nightstar Therapeutics Ltd | NITE | Disposition | Stock Option (Right to Buy) | 21k | $13.57 | $285k | | 06/07/2019 |
06/07/2019 | Nightstar Therapeutics Ltd | NITE | Disposition | Stock Option (Right to Buy) | 18.2k | $12.27 | $223.3k | | 06/07/2019 |
|